ArticleThe journal of headache and pain2019

Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.

William B Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.